Patents
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
06/2000
06/02/2000CA2351354A1 Hexapeptide with the stabilized disulfide bond and derivatives thereof regulating metabolism, proliferation, differentiation and apoptosis
06/02/2000CA2351311A1 Uses for eph receptor antagonists and agonists to treat vascular disorders
06/02/2000CA2350405A1 Method of using pon-1 to decrease atheroma formation
06/02/2000CA2350395A1 Nucleotide and protein sequences of nogo genes and methods based thereon
06/02/2000CA2349555A1 Composition and use of rar antagonists for promoting chondrogenesis
06/02/2000CA2349290A1 Retro-inversion peptides that target gastro-intestinal tract transport receptors and use thereof
05/2000
05/31/2000EP1004674A1 Human adamts-1 protein, gene coding for the same, pharmaceutical composition, and method for immunologically assaying human adamts-1 protein
05/31/2000EP1004670A2 Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents
05/31/2000EP1004669A1 Novel differentiation inhibitor
05/31/2000EP1004666A1 Protein having pdz domain sequence
05/31/2000EP1004664A1 Compositions and methods using lactadherin or variants thereof
05/31/2000EP1004595A2 Lytic and proliferative peptides and their use as pharmaceutic and phytopharmaceutic agents
05/31/2000EP1004319A1 Remedies for solid tumor containing wilms' tumor gene (wt1) expression inhibitors
05/31/2000EP1004315A1 Preventives and/or remedies for systemic lupus erythematosus containing anti-il-6 receptor antibody as the active ingredient
05/31/2000EP1004313A1 Cachexia remedy
05/31/2000EP1004312A1 Method for treating multiple sclerosis
05/31/2000EP1004302A2 Immunomodulator
05/31/2000EP1003898A1 Integrin-targeting vectors having transfection activity
05/31/2000EP1003897A1 Complexes for transporting nucleic acid into eukaryotic higher-cells
05/31/2000EP1003894A2 Lentiviral vectors
05/31/2000EP1003880A2 Human ubiquitin carrier protein e2-like protein and cyclin b-like protein
05/31/2000EP1003870A1 A polynucleotide functionally coding for the lhp protein from mycobacterium tuberculosis, its biologically active derivative fragments, as well as methods using the same
05/31/2000EP1003866A1 Method for identifying and locating expressed epil peptides, coded by the insl4 gene and their uses
05/31/2000EP1003862A1 Human longevity-assurance protein homologs
05/31/2000EP1003861A2 Mammalian cell membrane proteins; related reagents
05/31/2000EP1003859A1 Use of transcription factor brn-3a
05/31/2000EP1003858A1 New human growth regulator protein
05/31/2000EP1003857A2 Secreted proteins and polynucleotides encoding them
05/31/2000EP1003856A1 Apaf-1, the ced-4 human homolog, an activator of caspase-3
05/31/2000EP1003855A2 Secreted proteins and polynucleotides encoding them
05/31/2000EP1003854A1 Antimicrobial peptides derived from ubiquicidine
05/31/2000EP1003851A2 Syncytial respiratory virus epitopes and antibodies comprising them, useful in diagnosis and therapy
05/31/2000EP1003850A1 Inhibitors of dna immunostimulatory sequence activity
05/31/2000EP1003842A1 Catalytic monoclonal antibodies for the in vivo transformation of corticosteroid prodrugs
05/31/2000EP1003787A2 Agent for the treatment and/or prophylaxis of microcirculation disorders
05/31/2000EP1003786A1 Peptide with radio protective effect
05/31/2000EP1003784A1 Novel peptides and polypeptides useful for regenerating the nervous system
05/31/2000EP1003783A2 Lipoprotein-regulating medicaments
05/31/2000EP1003782A1 Ligand for herpes simplex virus entry mediator and methods of use
05/31/2000EP1003781A1 Interleukin-18 binding proteins, their preparation and use
05/31/2000EP1003780A1 Human f11 antigen: a cell surface receptor involved in platelet aggregation
05/31/2000EP1003777A1 PGC-1, A NOVEL BROWN FAT PPAR$g(g) COACTIVATOR
05/31/2000EP1003776A1 Gene and amino acid sequences for novel transcription factor
05/31/2000EP1003775A2 Hepatitis c inhibitor peptides
05/31/2000EP1003774A1 GnRH ANTAGONISTS BEING MODIFIED IN POSITIONS 5 AND 6
05/31/2000EP1003772A1 Chemical modification of proteins to improve biocompatibility and bioactivity
05/31/2000EP1003771A1 Linear peptides derived from antibiotic peptides, preparation and use for vectoring active substances
05/31/2000EP1003770A1 Secreted proteins and polynucleotides encoding them
05/31/2000EP1003768A1 Secreted proteins and polynucleotides encoding them
05/31/2000EP1003767A1 Human tumor necrosis factor receptor tr10
05/31/2000EP1003763A1 83 human secreted proteins
05/31/2000EP1003577A1 Blood product delivery system
05/31/2000EP1003552A1 LO-CD2a ANTIBODY AND USES THEREOF FOR INHIBITING T CELL ACTIVATION AND PROLIFERATION
05/31/2000EP1003550A1 Receptor specific transepithelial transport of therapeutics
05/31/2000EP1003548A1 A method of inducing a ctl response
05/31/2000EP1003547A1 Agonist murine monoclonal antibody as a stimulant for megakaryocytopoiesis
05/31/2000EP1003546A1 Methods for treatment of patients afflicted wih multiple sclerosis using consensus interferon
05/31/2000EP1003545A1 Heparin-binding growth factor (hbgf) polypeptides
05/31/2000EP1003544A1 C1q AND COLLECTIN RECEPTOR
05/31/2000EP1003543A1 Apoptosis-inducing gelsolin sequences
05/31/2000EP1003542A1 Use of substances having oxytocin activity for preparation of medicaments for wound healing
05/31/2000EP1003541A1 Inhibitors of hiv reverse transcriptase
05/31/2000EP1003540A1 $g(b)2-ADRENERGIC RECEPTOR AGONISTS
05/31/2000EP1003539A1 FLUORESCENT AMYLOID A$g(b) PEPTIDES AND USES THEREOF
05/31/2000EP1003533A1 Use of herpes vectors for tumor therapy
05/31/2000EP1003532A1 Absorption of minerals by intestinal cells
05/31/2000EP1003530A1 Eye treatments using synthetic thyroid hormone compositions
05/31/2000EP1003526A1 Covalently linked n,o-carboxymethylchitosan and uses thereof
05/31/2000EP1003500A1 Intramural delivery of nitric oxide enhancer for inhibiting lesion formation after vascular injury
05/31/2000EP1003483A1 Tannic acid-polymer compositions for controlled release of pharmaceutical agents, particularly in the oral cavity
05/31/2000EP1003481A1 Fibrinogen-coated microspheres
05/31/2000EP1003480A1 Conjugated peptide nucleic acids having enhanced cellular uptake
05/31/2000EP1003478A1 Aqueous aerosol preparations containing biologically active macromolecules and method for producing the corresponding aerosols
05/31/2000EP1003379A1 Novel phytase
05/31/2000EP1003370A1 Method of enhancing magnesium absorption and prevention of atherosclerosis
05/31/2000EP1003365A1 Atrial natriuretic factor mutants and ischemic stroke
05/31/2000EP0944650B1 Antithrombotic peptides derived from fibronectin type ii repeats
05/31/2000EP0939651B1 Materials and methods relating to the diagnosis and treatment of pre-eclampsia
05/31/2000EP0828854B1 Analytical and therapeutic agents
05/31/2000EP0818462A4 Peptide and a method of obtaining it
05/31/2000EP0747033B1 Transfusion liquid-containing holder and prepared transfusion liquid
05/31/2000EP0746337B1 Verotoxin pharmaceutical compositions and medical treatments thereof
05/31/2000EP0728207B1 Telomerase activity assays
05/31/2000EP0635016B1 Benzodiazepine derivatives and protein and polypeptide conjugates thereof
05/31/2000EP0631619B1 Reconstituted cartilage tissue
05/31/2000EP0584082B1 Domains of extracellular region of human platelet derived growth factor receptor polypeptides
05/31/2000EP0464022B1 Insulinotropic hormone
05/31/2000DE19854749A1 Verwendung von Kapseln, die eine oder mehrere antigene Substanzen enthalten, zur Prävention und/oder Behandlung von Autoimmunerkrankungen The use of capsules which contain one or more antigenic substances, for the prevention and / or treatment of autoimmune diseases
05/31/2000CN1255164A Modified antisense nucleotides complementary to section of human Ha-Ras gene
05/31/2000CN1255163A Compounds
05/31/2000CN1255162A Protease inhibitors
05/31/2000CN1255143A Novel strain of bacillus for controlling plant diseases and corn rootworm
05/31/2000CN1255066A Plant extracts for the treatment of increase bone resorption
05/31/2000CN1255063A Photosensitizer conjugates for pathogen targeting
05/31/2000CN1255044A Orally active fraction of momordica charactia, active peptides thereof, and their use in the treatment of diabetes
05/31/2000CN1254729A Biologic medical equipment with antimicrobe coating
05/31/2000CN1254558A S-(3-hydroxypropyl)-L-cysteine composition as oral medicine
05/30/2000US6069242 Mixture of pharmaceutically acceptable carrier and antisense nucleic acid; for diagnosis, imaging, anticarcinogenic agents, antitumor agents
05/30/2000US6069239 Expression system present in compatible host cell which produces a ligand regulated transcription factor; antiinflammatory/antiarthritic/antidiabetic agents; treatment of autoimmune diseases; diagnosis of related diseases
05/30/2000US6069236 Desalting, chromatography on anion exchange gel, viral deactivation using solvent-detergent treatment, chromatography on cation exchange gel, recovering; does not cause aggregate-induced complement activation